Two U.S. Food and Drug Administration (FDA)-approved drugs for treating prostate cancer may also be effective against acute ...

A superbug that does not respond to the very last ditch antibiotics and that has been circulating in Asia and Europe arrives ...

Researchers have discovered that prostate cancer depends on two key enzymes, PDIA1 and PDIA5, to survive and resist therapy.

Dog owners must watch for signs of urinary tract infections. These infections can cause pain and lead to serious health ...

The FDA-approved drug Pluvicto offers hope for advanced prostate cancer patients, but access barriers remain despite proven ...

Adding PARP inhibitor niraparib to standard prostate cancer treatment delayed disease progression in men with certain DNA repair gene mutations. The corresponding study was published in Nature ...

Former President Joe Biden is marking a milestone in his ongoing prostate cancer treatment. The 82-year-old Biden on Monday finished a round of radiation therapy to treat the aggressive form of cancer ...

An international research team led by the Medical University of Vienna has demonstrated for the first time that thyroid hormone plays a key role in the development and progression of prostate cancer.

A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, lowering the risk of death after eight years by 40.3%. What's more, the drug ...

One of the pillars of modern medicine is showing its cracks, according to a new report from the World Health Organization. Antibiotics have turned once-deadly infections into minor inconveniences.